Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Role of Circulating Tumor DNA As a Prognostic Biomarker in Patients with Diffuse Large B-Cell Lymphoma

Mayur S. Narkhede, Sarah Tomassetti, Madiha Iqbal, Antony Tin, Samuel Rivero-Hinojosa, Giby V. George, Hayley Widden, Ryan Benrud, Angel Rodriguez, Minetta C. Liu

Blood (2023) 142 (Supplement 1): 4376.

https://doi.org/10.1182/blood-2023-186603

Published: 2023

Journal Articles

Higher Rates of Severe Infection and Persistent Cytopenias in Long-Term CAR19 Responders Than after Autologous HCT: A Single Institution Study of 139 Subjects

Blood (2022) 140 (Supplement 1): 7545–7547.

https://doi.org/10.1182/blood-2022-165600

Published: 2022

Journal Articles

Identification of a Novel Role for PD-1 Signaling in Promotion Tumor Proliferation in B-Cell Lymphoma

Blood (2020) 136 (Supplement 1): 10–12.

https://doi.org/10.1182/blood-2020-136550

Published: 2020

Journal Articles

Genomic Profiling Reveals Molecular Heterogeneity in Patients with Richter's Syndrome (RS) and Progressive Chronic Lymphocytic Leukemia (CLL)

Shulan Tian, MS, PhD, Hanyin Wang, MD, Timothy G. Call, MD, Eric W. Klee, PhD, Minetta C. Liu, MD, Erik Jessen, PhD, Sameer A. Parikh, MD, Yucai Wang, MDPhD, Saad S. Kenderian, MB, ChB, Jose F. Leis, MD PhD, Min Shi, MDPhD, Eli Muchtar, MD, Daniel L. Van Dyke, PhD, Amber B. Koehler, PA-C, MS, Neil E. Kay, MD, Susan L. Slager, PhD, Esteban Braggio, PhD, Huihuang Yan, PhD, Wei Ding, MD PhD

Blood (2020) 136 (Supplement 1): 16–17.

https://doi.org/10.1182/blood-2020-138397

Published: 2020

Journal Articles

Molecular Alterations in Adult Histiocytic Neoplasms

Gaurav Goyal, MBBS, Jithma P. Abeykoon, MD, Nora N Bennani, MD, Minetta C Liu, MD, Mithun Vinod Shah, MD PhD, Ronald S. Go, MD

Blood (2019) 134 (Supplement_1): 2975.

https://doi.org/10.1182/blood-2019-122286

Published: 2019

Journal Articles

Tumor mutational burden and other predictive immunotherapy markers in histiocytic neoplasms

Gaurav Goyal, Denise Lau, Alison M. Nagle, Robert Vassallo, Karen L. Rech, Jay H. Ryu, Caroline J. Davidge-Pitts, W. Oliver Tobin, Matthew J. Koster, N. Nora Bennani, Mithun V. Shah, Minetta C. Liu, Ronald S. Go

Blood (2019) 133 (14): 1607–1610.

https://doi.org/10.1182/blood-2018-12-893917

Published: 2019

Includes: Supplemental data

Journal Articles

Impact of Race on Outcomes in Intermediate Risk Acute Myeloid Leukemia

Ivy Abraham, MD, Anand Ashwin Patel, MD, Yanyu Zhang, Li C Liu, PhD, Olga Frankfurt, MD, Irum Khan, MBBS

Blood (2018) 132 (Supplement 1): 3603.

https://doi.org/10.1182/blood-2018-99-115156

Published: 2018

Journal Articles

PD-1 Overexpression in Richter's Transformation (RT) and Aggressive Chronic Lymphocytic Leukemia (CLL) after Progression on Ibrutinib Increases Bcl-2 Expression Via Akt/mTOR Pathway

Sutapa Sinha, PhD, Tammy Price-Troska, BS, Shulan Tian, MS, PhD, Charla R Secreto, Xiaosheng Wu, MD, Timothy G. Call, MD, Rong He, MD, Sameer A. Parikh, MD, Saad S. Kenderian, MD, Jose F. Leis, MD PhD, Huihuang Yan, PhD, Karen L Rech, MD, Minetta C Liu, MD, Stephen M. Ansell, MD PhD, Neil E. Kay, MD, Wei Ding, MD PhD

Blood (2018) 132 (Supplement 1): 586.

https://doi.org/10.1182/blood-2018-99-112575

Published: 2018

Journal Articles

Tumor Mutational Burden and Other Immunotherapy Markers in Histiocytic Neoplasms Using Next Generation Sequencing

Gaurav Goyal, MBBS, Robert Vassallo, MD, Karen L Rech, MD, Jay H Ryu, MD, Caroline J Davidge-Pitts, MBBCh, W Oliver Tobin, MBBCh, PhD, Matthew J Koster, MD, Nabila Nora Bennani, MD, Mithun Vinod Shah, MD PhD, Minetta C Liu, MD, Ronald S. Go, MD

Blood (2018) 132 (Supplement 1): 1112.

https://doi.org/10.1182/blood-2018-99-113196

Published: 2018

Journal Articles

Validation of FOXM1 As a Therapeutic Target in Acute Myeloid Leukemia

Irum Khan, MBBS, Anand Ashwin Patel, MD, Marianna Halasi, Rachael Schultz, BA, Yi-Hua Chen, MD, Nathan Aardsma, DO, Nandini Kalakota, MD, Li C Liu, PhD, Nadim Mahmud, MBBS, PhD, Peter Gann, MD, Olga Frankfurt, MD, Andrei Gartel, PhD

Blood (2017) 130 (Supplement 1): 300.

https://doi.org/10.1182/blood.V130.Suppl_1.300.300

Published: 2017

Journal Articles

RANK-RANKL Mediated Bone Destruction in B-Cell Acute Lymphoblastic Leukemia

Sujeetha A. Rajakumar, MSc, Eniko Papp, PhD, Ildiko Grandal, MSc, Daniele Merico, PhD, Careesa C. Liu, MSc, Bedilu Allo, PhD, Lucia Zhang, Marc Grynpas, PhD, Mark D. Minden, MD PhD, Johann K. Hitzler, MD, Cynthia J. Guidos, PhD, Jayne S. Danska, PhD

Blood (2016) 128 (22): 908.

https://doi.org/10.1182/blood.V128.22.908.908

Published: 2016

Journal Articles

B-cell survival and development controlled by the coordination of NF-κB family members RelB and cRel

Jonathan V. Almaden, Yi C. Liu, Edward Yang, Dennis C. Otero, Harry Birnbaum, Jeremy Davis-Turak, Masataka Asagiri, Michael David, Ananda W. Goldrath, Alexander Hoffmann

Blood (2016) 127 (10): 1276–1286.

https://doi.org/10.1182/blood-2014-10-606988

Published: 2016

Includes: Supplemental data

Journal Articles

SB1518: A Potent and Orally Active JAK2 Inhibitor for the Treatment of Myeloproliferative Disorders.

Blood (2007) 110 (11): 538.

https://doi.org/10.1182/blood.V110.11.538.538

Published: 2007

Journal Articles

Cure of multidrug-resistant human B-cell lymphoma xenografts by combinations of anti-B4-blocked ricin and chemotherapeutic drugs

C Liu, JM Lambert, BA Teicher, WA Blattler, R O'Connor

Blood (1996) 87 (9): 3892–3898.

https://doi.org/10.1182/blood.V87.9.3892.bloodjournal8793892

Published: 1996

Journal Articles

Anti-B4-blocked ricin synergizes with doxorubicin and etoposide on multidrug-resistant and drug-sensitive tumors

R O'Connor, C Liu, CA Ferris, BC Guild, BA Teicher, C Corvi, Y Liu, RJ Arceci, VS Goldmacher, JM Lambert

Blood (1995) 86 (11): 4286–4294.

https://doi.org/10.1182/blood.V86.11.4286.bloodjournal86114286

Published: 1995

Journal Articles

The Amino Acid Composition of Hemoglobin. II. Analytical Technics

AMOZ I. CHERNOFF, JEVONS C. LIU, E. Battle, M. Bond

Blood (1961) 17 (1): 54–70.

https://doi.org/10.1182/blood.V17.1.54.54

Published: 1961

NARROW

Role of Circulating Tumor DNA As a Prognostic Biomarker in Patients with Diffuse Large B-Cell Lymphoma

Higher Rates of Severe Infection and Persistent Cytopenias in Long-Term CAR19 Responders Than after Autologous HCT: A Single Institution Study of 139 Subjects

Identification of a Novel Role for PD-1 Signaling in Promotion Tumor Proliferation in B-Cell Lymphoma

Genomic Profiling Reveals Molecular Heterogeneity in Patients with Richter's Syndrome (RS) and Progressive Chronic Lymphocytic Leukemia (CLL)

Molecular Alterations in Adult Histiocytic Neoplasms

Tumor mutational burden and other predictive immunotherapy markers in histiocytic neoplasms

Impact of Race on Outcomes in Intermediate Risk Acute Myeloid Leukemia

PD-1 Overexpression in Richter's Transformation (RT) and Aggressive Chronic Lymphocytic Leukemia (CLL) after Progression on Ibrutinib Increases Bcl-2 Expression Via Akt/mTOR Pathway

Tumor Mutational Burden and Other Immunotherapy Markers in Histiocytic Neoplasms Using Next Generation Sequencing

Validation of FOXM1 As a Therapeutic Target in Acute Myeloid Leukemia

RANK-RANKL Mediated Bone Destruction in B-Cell Acute Lymphoblastic Leukemia

B-cell survival and development controlled by the coordination of NF-κB family members RelB and cRel

SB1518: A Potent and Orally Active JAK2 Inhibitor for the Treatment of Myeloproliferative Disorders.

Cure of multidrug-resistant human B-cell lymphoma xenografts by combinations of anti-B4-blocked ricin and chemotherapeutic drugs

Anti-B4-blocked ricin synergizes with doxorubicin and etoposide on multidrug-resistant and drug-sensitive tumors

The Amino Acid Composition of Hemoglobin. II. Analytical Technics

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only